• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T510
Device Problems Gradient Increase (1270); Occlusion Within Device (1423)
Patient Problems Congestive Heart Failure (1783); High Blood Pressure/ Hypertension (1908); Mitral Valve Stenosis (1965)
Event Date 01/23/2013
Event Type  Injury  
Manufacturer Narrative
Citation: thorac cardiovasc surg.2014 apr;62(3):261-4.Doi: 10.1055/s-0032-1333137.Date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature of a (b)(6) female patient with mitral valve regurgitation secondary to infective endocarditis who underwent implant of a 29 mm medtronic hancock ii (serial number not provided).Twelve years following the implant, echocardiogram revealed stenosis with an increased mean gradient of 31 mmhg.Congestive heart failure with a systolic pulmonary artery pressure of 78 mmhg due to increased pulmonary vascular resistance was noted.Cardiopulmonary bypass (cpb) was performed and the valve was replaced with a mechanical valve.No additional adverse patient effects were reported.
 
Event Description
Additional information received from the physician/author stated that the 12 years of implant period was acceptable in terms of the device durability.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6501368
MDR Text Key73074996
Report Number2025587-2017-00606
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberT510
Device Catalogue NumberT510
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/04/2017
Initial Date FDA Received04/18/2017
Supplement Dates Manufacturer ReceivedNot provided
05/18/2017
Supplement Dates FDA Received05/19/2017
10/03/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age35 YR
-
-